<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220528055008N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-07-17</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of lavender and rosemary essential oil on nausea and vomiting in chemotherapy patients</public_title>
      <acronym>LRH</acronym>
      <scientific_title>Comparion of aromatherapy with essential oils of  Lavender and Rose on nausea and vomiting in patients undergoing chemotherapy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-07-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63897</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Factorial, Purpose: Supportive, Randomization description: Sampling will be available and then random allocation will be done, and every day each of the research samples that meet the criteria for entering the study will randomly select an envelope from among the sealed envelopes. In this way, the group Rosemary, Stochodos, placebo, and mixed (rosemary and Stochodos in a ratio of 3 to 2) are assigned to complete the sample size in each group and all 4 groups.
The method of blinding is in the form of a blind. Only the patients did not know which group they were in. Patients receiving the scent are hospitalized in separate rooms, Blinding description: Glasses of essential oils and distilled water have the same shape, size, and color.</study_design>
      <phase>3</phase>
      <hc_freetext>Nausea of chemotherapy patients.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Lavender essential oil group, chemical compounds linalyl acetate 25-47, linalool 20-45, cineol maximum 2.5%, limonene maximum 1%, camphor maximum 1.2%, alpha-terpineol maximum 2%, baric essential oil company, 3 drops of essential oil Shed 10-15 cm from the nose is inhaled from 22 to 6 in the morning for 8 hours. Intervention 2: Rose essential oil group, 100% distilled rose essential oil compositions, and 3 drops of rose essential oil from Barich Essential Oil Company are poured on a napkin and placed at a distance of 10-15 cm from the nose from 22:00 to 6:00 in the morning and inhaled for 8 hours. Be. Intervention 3: Intervention group: Combined group of ostrich essential oil and rose, 2 drops of ostrich essential oil of Barich Essential Oil Company, including linalyl acetate 25-47, linalool 20-45, cineol maximum 2.5%, limonene maximum 1%, camphor maximum 1.2%, alpha-terpineol maximum 2% and 3 rose essential oils Baric Company puts 100% rose essential oil on a napkin at a distance of10-15 cm from the nose and is inhaled from 22:00 to 6:00 in the morning. Intervention 4: Control group: Placebo group: 3 drops of distilled water is placed on a napkin at a distance of 10-15 cm from the nose and is inhaled from 8 pm to 6 am for 8 hours.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Kordvarkaneh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 47,Tima One Alley, Al-Ghadir Boulevard, Imam Hossein Square, Hamedan.</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6513745373</zip>
        <telephone>+98 81 3274 7386</telephone>
        <email>zahrakordvarkane955@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Kordvarkaneh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 47,Tima One Alley, Al-Ghadir Boulevard, Imam Hossein Square, Hamedan.</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6513745373</zip>
        <telephone>+98 81 3274 7386</telephone>
        <email>zahrakordvarkane955@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Do not use aromatherapy in the past month
No allergic rhinitis, asthma, chronic lung disease, sleep disorders, and other chronic diseases that affect the sense of smell
No history of allergy to medicinal plants
Have a course of at least 3 days of chemotherapy.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Occurrence of a stressful event: death of relatives, divorce, etc. during the study
Using other complementary medicine interventions while studying
Symptoms of sensitivity to the used fragrance
Having pain while studying</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Lavender essential oil group, chemical compounds linalyl acetate 25-47, linalool 20-45, cineol maximum 2.5%, limonene maximum 1%, camphor maximum 1.2%, alpha-terpineol maximum 2%, baric essential oil company, 3 drops of essential oil Shed 10-15 cm from the nose is inhaled from 22 to 6 in the morning for 8 hours.</i_keyword>
      <i_keyword>Rose essential oil group, 100% distilled rose essential oil compositions, and 3 drops of rose essential oil from Barich Essential Oil Company are poured on a napkin and placed at a distance of 10-15 cm from the nose from 22:00 to 6:00 in the morning and inhaled for 8 hours. Be.</i_keyword>
      <i_keyword>Intervention group: Combined group of ostrich essential oil and rose, 2 drops of ostrich essential oil of Barich Essential Oil Company, including linalyl acetate 25-47, linalool 20-45, cineol maximum 2.5%, limonene maximum 1%, camphor maximum 1.2%, alpha-terpineol maximum 2% and 3 rose essential oils Baric Company puts 100% rose essential oil on a napkin at a distance of10-15 cm from the nose and is inhaled from 22:00 to 6:00 in the morning.</i_keyword>
      <i_keyword>Control group: Placebo group: 3 drops of distilled water is placed on a napkin at a distance of 10-15 cm from the nose and is inhaled from 8 pm to 6 am for 8 hours.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Nausea score on visual analog scale is less than 5. Timepoint: Measurement of nausea at the beginning of the intervention (before the intervention) and 1, 2, 3 and the day after inhalation of lavender, rose and placebo essential oils. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-06</approval_date>
        <contact_name>Research Ethics Committee of Hamadan University of Medical Sciences</contact_name>
        <contact_address>No. 47,Tima One Alley, Al-Ghadir Boulevard, Imam Hossein Square, Hamedan. Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
